Pharma Industry News

Atyr Pharma: Q1 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Friday reported a loss of $10.8 million in its first quarter. The San Diego-based company said it had a loss of 11 cents per share. The company's shares closed at 56 cents.

ARS Pharma (SPRY) Q4 2025 Earnings Transcript

Monday, March 9, 2026, at 8:30 a.m. ET Chief Executive Officer — Richard Lowenthal Chief Commercial Officer — Eric Karas Chief Financial Officer — Kathleen Scott Need a quote from a Motley Fool analyst? Email [email protected]…

Another pharma giant eyes Houston for $1B plant with hundreds of jobs possible

Houston Business Journal New Jersey-based Bristol Myers Squibb said it would create nearly 500 jobs at the site. HOUSTON — Another pharmaceutical heavyweight is considering Houston for its domestic manufacturing operations, following several…

Michael Burry's Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why

Pfizer (PFE) trades at $25.75 with a rare 6.66% dividend yield and 9x forward P/E, offering upside. Molina and Halliburton join Pfizer as defensive cash generators with structural edges through pricing power and margin stability. This post may…

This startup wants to make drugs in orbit. If it succeeds, it could transform the space economy

A start-up's plan to run drug experiments and even develop pharmaceuticals in orbit is taking shape. If it works, it could mark a step toward developing new medicines and, ultimately, a burgeoning space-based manufacturing industry. The start-up in…

Olema Stock: The Market Overreacted To Roche's SERD Failure (NASDAQ:OLMA)

Olema Pharmaceuticals is rated a cautious buy, with upside potential tied to pivotal OPERA-01 Phase 3 trial results expected in fall 2026. Palazestrant differentiates itself as a CERAN with superior mechanistic action, favorable pharmacokinetics…

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Bristol Myers Squibb this week announced a partnership with Hengrui Pharma to develop drugs together. American and European biopharmaceutical companies are increasingly looking to China for their next blockbusters. Bristol's deal is unique because…

American Century Small Cap Value Fund Q1 2026 Commentary (Mutual Fund:ASVIX)

The fund's significant overweight in energy, particularly holdings like Crescent Energy, Permian Resources, and Magnolia Oil & Gas, contributed positively as oil prices surged due to Middle East conflict. ASVIX remains underweight health care…

Call Them Gamblers or Investors, They're Moving Stocks

India's West Asia Trade Declines 28% in April Amid Shipping Disruptions, War Impact

India's trade with the West Asian region experienced a notable contraction for the second consecutive month in April, with both exports and imports declining by over 28%, primarily due to severe shipping disruptions caused by the ongoing conflict…

Heron Bay Doubles Down on Vontier, Buying 1.37 Million Shares

According to a Securities and Exchange Commission (SEC) filing dated May 13, 2026, Heron Bay Capital Management acquired an additional 1,370,006 shares of Vontier (VNT 2.40%), during the first quarter. The estimated transaction value is $52.76…

Trump's flavored vape push sparks backlash from some MAHA influencers and administration officials

The Trump administration's recent moves to make flavored e-cigarettes and vapes more widely available have caused a splintering among prominent voices in the MAHA movement and even some federal health officials. Health Secretary Robert F. Kennedy's…

IT lifts indices at midday; metals, retail stocks pull back

Markets were holding steady with marginal gains in afternoon trade on Friday, May 15, as buying in information technology and select heavyweights offset losses in metals, retail and energy stocks. At 12.30 pm, the Sensex was trading at 75,483.07…

The Broyhill Q1 2026 Letter

Broyhill Asset Management, LLC (“Broyhill” or the “Firm”) is a Charlotte-based investment firm managing over $270 million in assets. Originally established as a family office nearly half a century ago, the firm spun out…

Pharmaceutical Takeda to layoff 4,500 people from global workforce

The pharma has four locations in Ireland, employing more than 1,000 professionals. Japanese pharmaceutical company Takeda has announced plans to cut 4,500 people from its globally dispersed workforce, as a means of restructuring and reducing costs.